Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPINE-ANI: ESPB vs IV Multimodal Analgesia in Lumbar Spine Surgery
NCT07455565Recruiting
- Sponsor
- Akdeniz University Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection, acetaminophen, morphine, dexamethasone and ketamine in postoperative pain (2 arms), sponsored by Akdeniz University Hospital. Primary endpoint: Analgesia Nociception Index at 24 hours. Started Dec 2025; status: recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injectionacetaminophenmorphinedexamethasoneketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07455565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07455565.